Business Description
Akums Drugs and Pharmaceuticals Ltd
ISIN : INE09XN01023
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.51 | |||||
Equity-to-Asset | 0.2 | |||||
Debt-to-Equity | 0.8 | |||||
Debt-to-EBITDA | 4.33 | |||||
Interest Coverage | 7.16 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14.3 | |||||
3-Year EBITDA Growth Rate | -19.3 | |||||
3-Year EPS without NRI Growth Rate | 14.1 | |||||
3-Year FCF Growth Rate | 57.5 | |||||
3-Year Book Growth Rate | -6.2 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 36.74 | |||||
9-Day RSI | 43.35 | |||||
14-Day RSI | 49.58 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.6 | |||||
Quick Ratio | 1.08 | |||||
Cash Ratio | 0.24 | |||||
Days Inventory | 96.52 | |||||
Days Sales Outstanding | 84.69 | |||||
Days Payable | 80.58 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.9 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 35.76 | |||||
Operating Margin % | 8.95 | |||||
Net Margin % | 0.02 | |||||
FCF Margin % | 4.65 | |||||
ROE % | 0.12 | |||||
ROA % | 0.02 | |||||
ROIC % | -0.24 | |||||
ROC (Joel Greenblatt) % | 0.22 | |||||
ROCE % | 0.23 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 17145 | |||||
PE Ratio without NRI | 49.81 | |||||
PS Ratio | 3.36 | |||||
PB Ratio | 18.5 | |||||
Price-to-Tangible-Book | 18.73 | |||||
Price-to-Free-Cash-Flow | 72.21 | |||||
Price-to-Operating-Cash-Flow | 27.08 | |||||
EV-to-EBIT | 2768.95 | |||||
EV-to-EBITDA | 105.42 | |||||
EV-to-Revenue | 3.43 | |||||
EV-to-FCF | 73.15 | |||||
Price-to-Graham-Number | 6.44 | |||||
Earnings Yield (Greenblatt) % | 0.04 | |||||
FCF Yield % | 1.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Akums Drugs and Pharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 40,196.82 | ||
EPS (TTM) (₹) | 0.05 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 49.58 | ||
14-Day ATR (₹) | 44.995992 | ||
20-Day SMA (₹) | 873.7775 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (₹) | 724.5 - 1174.85 | ||
Shares Outstanding (Mil) | 157.39 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Akums Drugs and Pharmaceuticals Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Akums Drugs and Pharmaceuticals Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Akums Drugs and Pharmaceuticals Ltd Frequently Asked Questions
What is Akums Drugs and Pharmaceuticals Ltd(BOM:544222)'s stock price today?
When is next earnings date of Akums Drugs and Pharmaceuticals Ltd(BOM:544222)?
Does Akums Drugs and Pharmaceuticals Ltd(BOM:544222) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |